OPEN ACCESS
PEER-REVIEWED
Original Study
| Published: August 03, 2021
Determinants of Anxiety and Depression in Patients with Covid 19 Admitted in a Tertiary Care Hospital of New Delhi, India
Professor, Department of Medicine, ABVIMS, Dr RML Hospital, New Delhi, India Google Scholar More about the auther
Assistant Professor, Department of Community Medicine, ABVIMS, Dr RML Hospital, New Delhi, India Google Scholar More about the auther
Professor, Department of Medicine, ABVIMS, Dr RML Hospital, New Delhi, India. Google Scholar More about the auther
Assistant Professor, Department of Medicine, ABVIMS, Dr RML Hospital, New Delhi, India. Google Scholar More about the auther
Professor, Department of Medicine, ABVIMS, Dr RML Hospital, New Delhi, India. Google Scholar More about the auther
Resident, Department of Medicine, ABVIMS, Dr RML Hospital, New Delhi, India. Google Scholar More about the auther
Resident, Department of Medicine, ABVIMS, Dr RML Hospital, New Delhi, India. Google Scholar More about the auther
Associate Professor, Department of Medicine, ABVIMS, Dr RML Hospital, New Delhi, India. Google Scholar More about the auther
DIP: 18.01.042.20210903
DOI: 10.25215/0903.042
ABSTRACT
Background: COVID 19 pandemic has significantly affected the mental health of patients, especially along with the lockdown crisis. The aim of this study was to assess the prevalence and determinants associated with depression and anxiety among the patients admitted with moderate COVID 19 in our hospital. Materials and Methods: It was a cross sectional descriptive study done in 100 admitted cases above 18 years of age. A predesigned proforma was filled along with laboratory investigations in fasting state. Hospital Anxiety and Depression Scale (HADS score) was used for the assessment of mental health of these patients. Results: Out of 100 admitted cases with moderate grade severity of COVID-19, the prevalence of anxiety and depression was found to be 31.25% and 47.4% respectively. Both anxiety and depression were found to be associated with low oxygen saturation (less than 85% on room air, higher class of steroids and anticoagulation respectively. Depression was also found to be associated with higher blood sugar and serum creatinine. Anxiety was found to have a direct correlation with high blood sugar, serum transaminases and serum ferritin levels and inverse relationship with use of the drug, ivermectin (p<0.027). Conclusion: Our study proves that there is a high prevalence of anxiety and depression in patients with COVID-19. Ivermectin should be a part of treatment of all moderate (or may be mild) cases suffering with this disease.
Keywords
Depression, Anxiety, COVID-19, Mental health, Steroids, Hypoxia, Ivermectin
This is an Open Access Research distributed under the terms of the Creative Commons Attribution License (www.creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any Medium, provided the original work is properly cited.
© 2021, Gupta P K, Panesar S, Chawla MPS, Jain P, Murthy S, Prakash O, Mangla S & Kaur G
Received: May 20, 2021; Revision Received: July 21, 2021; Accepted: August 03, 2021
Article Overview
ISSN 2348-5396
ISSN 2349-3429
18.01.042.20210903
10.25215/0903.042
Download: 19
View: 638
Published in Volume 09, Issue 3, July- September, 2021